1987: WHO Admits Its Smallpox Vaccine Caused AIDS - WHO Omits That It Requested The Virus

1987: WHO Admits Its Smallpox Vaccine Caused AIDS - WHO Omits That It Requested The Virus

"[A] 1972 report (Bulletin #47) issued by the World Health Organization .... referred to an immune virus requested [Emphasis added] which would selectively destroy the Human T Cell System, to be distributed in conjunction with a Nationwide vaccination program "to observe the results". This coincided precisely with the extensive Small Pox vaccination program in central Africa - shortly preceding the outbreak of Aids in Africa, America & elsewhere. The determining factor most common in Aids victims is the breakdown of the T Cell System in the body."

From http://www.thepetitionsite.com/1/a-universal-declaration-of-resistance-to-mandatory-vaccinations/

 

Below is an article describing how the WHO attempted to deal with those who saw and questioned the obvious connection between the WHO's massive smallpox vaccine campaign and the outbreak of AIDS in all the places it gave it.

 

Before reading the following article about the WHO and the smallpox vaccine, please be aware of seven things. 

1.  People have seen that ebola suddenly broke out in each of the places the WHO (and UN and UNICEF and Doctors without Borders) recently ran vaccine campaigns in West Africa.

2.  Ebola is a man-made bioweapons owned and patented by the US government and the CDC.

3.  The WHO now, on the basis of ebola outbreaks that coincided with its own vaccine campaign,  now plans a massive vaccine campaign against ebola with untested vaccines that will contain the ebola virus (a bioweapon) that can cause ebola and mass deaths.

4.  The US is interested in the oil, diamonds and minerals in West Africa, has been stopped by people living there, but, because of an "ebola emergency" claimed by the WHO after there were outbreaks of ebola following the WHO vaccine campaigns there, now has 1000s of troops in West Africa.

5.  The US and other countries who contribute to the WHO were also interested in the mineral wealth of Central Africa prior to the WHO's smallpox vaccination campaign.

6.  The pharmaceutical industry which was the main supporters of Hitler and intensely interested in genocide, became the main supporters of the WHO, coincidentally formed immediately after WWII, was involved in killing millions with the smallpox vaccines.  They coincidentally made an immense fortune on AIDS drugs and research funding, all the while not revealing that the WHO had requested an AIDS-like virus just prior to the pharmaceutical industry making the small pox vaccine and AIDS breaking out immediately afterwards.

 

7.  This WHO vaccine campaign issue is not a historical issue because Bush's pandemic laws and the WHO International Health Regulations would make vaccines mandatory now if the WHO declares a  pandemic emergency (with no proof needed) and even if people believed they could cause more AIDS or cause ebola and deadly.  Then, it would be Americans, not just Africans hiding from vaccines or killing vaccine teams because the vaccines are killing tens of thousands of children. 

http://exopolitics.blogs.com/ebolagate/2014/11/1987-who-admits-smallpox-vaccine-caused-aids-who-omits-that-it-requested-it.html

From http://www.wanttoknow.info/870511vaccineaids

Berlin Patient, first person cured of HIV, may soon have company

Berlin Patient, first person cured of HIV, may soon have company

July 27, 2012|By Erin Loury | Los Angeles Time

Timothy Brown, a.k.a. the Berlin Patient, is the only person considered cured of HIV, but others may join those ranks soon. (EPA/MICHAEL REYNOLDS )

http://articles.latimes.com/2012/jul/27/news/la-heb-hiv-cure-aids-meeting-20120727

Washington, D.C. — The Berlin Patient, the only person considered cured of HIV, may soon have some company.
Researchers at the International AIDS Conference in Washington, D.C., made presentations Thursday on two HIV-positive men from Boston who developed lymphoma. In both cases, their treatment included a bone marrow transplant, which results in a new immune system. The bone marrow donors did not have HIV.

The patients were conditioned for their transplants with a reduced-intensity protocol that allowed them to maintain enough strength to continue taking antiretroviral drugs to keep their HIV in check. These drugs are usually too toxic for HIV-positive cancer patients to handle.
So far, it appears that their new immune systems have remained HIV-free. Seventeen months after the transplants, researchers could not detect any HIV genetic material in the patients’ blood. They say the credit for this goes to the antiretroviral drugs the patients are taking.
Still unclear is whether the virus still lurks in the patients’ tissues. “It is possible that there is still other residual HIV material, “said study author Dr. Timothy Henrich of Harvard University and Brigham and Women's Hospital. If doctors became convinced that all trace of the virus is gone, the patients could stop taking the antiretroviral drugs and be considered cured.
But they’re not there yet.
“We’re being very careful to refer to our patients as not being functionally cured,” said study author Daniel Kuritzkes, also of Harvard University and Brigham and Women's Hospital. Only when these patients can successfully stop their medication can they be considered cured of HIV.
The only person in that category right now is the Berlin Patient, a.k.a. Timothy Brown. He had a bone marrow transplant to treat acute myeloid leukemia. In his case, the bone marrow donor was not only HIV-negative, but had a rare genetic mutation that blocks HIV from entering cells. That effectively makes Brown immune to the virus, and his body has remained HIV-free even without taking antiretroviral drugs.
The two patients in Boston received their bone marrow transplants from people who did not have the rare genetic variant, which is why they are still taking their drugs.
Researchers are working on potential cures that involve transferring that genetic mutation to HIV-positive patients without taking on the significant risks of a bone marrow transplant.
Another study presented Thursday reported on 12 French HIV-positive patients who received early treatment and have acquired an ability to naturally control HIV.  These patients offer hope that it may be possible to “functionally” cure the disease – enabling people to tolerate HIV without completing ridding their bodies of the virus.
The patients started taking antiretroviral medication within 10 weeks of their HIV infections and stopped about three years later.  Now, nearly seven years after ending treatment, these patients still have very low levels of the virus in their bodies. They appear similar to a small group of people known as “elite controllers” who naturally suppress HIV to low levels and do not get sick from the virus.
Reservoirs of dormant HIV can occur throughout the body. This sleeping HIV can periodically wake up and re-infect a person, which is why people with HIV usually have to take medication for life.

The French patients still have very low reservoirs of virus in their bodies, and researchers wondered if their ability to manage the virus related to how these remaining patches of HIV were distributed among a type of white blood cells called memory T cells. Pockets of HIV usually build up in long-lived types of memory T cells. However, researchers found that this rare cohort had dormant HIV primarily in shorter-lived memory T cells – similar to elite controllers – so their infected cells don’t persist as long.
The results provide further evidence that antiretroviral therapy should be started soon after infection, researchers said.
To wipe out all traces of HIV, scientists must find a way to wake up reservoirs of sleeping virus and target them with drugs. Jerome Zack, director of the UCLA Center for AIDS Research, made a presentation about this approach.
Zack and his colleagues outfitted little lipid bubbles called liposomes with antibodies that specifically match up with CD4 cells, the type of white blood cell that HIV usually attacks. The liposomes deliver two drugs to the cell – one, called bryostatin, switches on cell activity, and the other, a protease inhibitor, prevents HIV virus from assembling more virus once it starts to reproduce.
These liposomes didn’t target or otherwise activate another type of white blood cells called CD8 cells. As a result, the treatment didn’t trigger toxic inflammation. However, scientists still need to figure out how to design liposomes that identify only the CD4 cells that are infected with dormant HIV.
Bryostatin is a useful molecule, but also exorbitantly expensive – a single gram can cost $1 million.
Zack and his colleagues published a paper in Nature Medicine last week that described a number of synthetic products that mimic bryostatin, and cost only about $2,000 per gram to manufacture. Zack said that a few of these compounds also outperform their natural counterpart in switching on latent HIV while triggering less inflammation.

Myanmar: Victims of Recent Clashes Must Have Access to Health Care

Myanmar: Victims of Recent Clashes Must Have Access to Health Care YANGON, MYANMAR, June 18, 2012—Continuing violence and deep communal divisions in Rakhine State, Myanmar, are preventing people from receiving emergency medical treatment, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today. MSF was forced to suspend most of its medical activities in Rakhine State when violence erupted on June 9, putting the organization’s clinics and staff in danger. “MSF is extremely worried that victims of the clashes are not receiving emergency care, and about the ongoing healthcare needs of our patients,” said Joe Belliveau, MSF operations manager. “Our immediate concerns are to provide emergency medical services, get food and supplies to people, and ensure our HIV patients continue receiving their lifesaving treatment.” In their effort to find a safe haven, people from Rakhine are trying to flee the violence for southern Bangladesh but are reportedly being denied access to the country. MSF provides medical services in Bangladesh, and is ready to treat anyone in need of assistance, regardless of origin. “People seeking refuge and who are in need of food, water, and medical care should be allowed to cross the border,” continued Belliveau. “In both Myanmar and Bangladesh, MSF is trying to reach those affected by the violence, but they should also be allowed to reach us.” In Rakhine, MSF has been providing medical services for 20 years, focusing on maternal health and infectious diseases such as malaria, diarrhea, HIV/AIDS, and TB. In 2011, MSF conducted more than 487,000 medical consultations. More than 600 people receive anti-retroviral treatment (ART) for HIV/AIDS. In addition to meeting immediate emergency needs, the resumption of MSF’s regular medical programs is critical for the longer-term health and well-being of people from all communities throughout the state. In all of its activities worldwide, MSF’s sole aim is to ensure that the most vulnerable people—regardless of ethnicity, origin or religion—receive the medical humanitarian assistance they require. MSF’s medical program in Myanmar is one of its largest anywhere in the world. MSF is the country’s main AIDS treatment provider and has been at the forefront of the fight against malaria. http://www.doctorswithoutborders.org/press/release.cfm?id=6080&cat=press-release